Loading...
ASCEND LABORATORIES,LLC — Cefuroxime Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #2 buyer for Cefuroxime · $2.7M import value · 73 shipments · UNITED STATES · DGFT Verified
ASCEND LABORATORIES,LLC is the #2 importer of Cefuroxime from India with $2.7M in import value and 73 verified shipments. ASCEND LABORATORIES,LLC holds a 0.1% market share in Cefuroxime imports based in UNITED STATES. The company sources from 1 verified supplier across 35 formulations shipped to 1 country. Overall, ASCEND LABORATORIES,LLC imports 25 pharmaceutical products worth $163.5M across 12 therapeutic categories.
Verified from 73 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| ALKEM LABORATORIES LIMITED | $2.7M | 73 | 100.0% |
ASCEND LABORATORIES,LLC sources Cefuroxime from 1 verified Indian supplier based on 73 customs records. The primary supplier is ALKEM LABORATORIES LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #2 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | M/S. RANBAXY FARMACEUTICA LTDA : | BRAZIL | $3.5M | 69 | $50.0K |
| 3 | ASCEND LABORATORIES,LLC ★ | UNITED STATES | $3.1M | 63 | $50.0K |
| 4 | YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $3.1M | 93 | $33.8K |
| 5 | APL SWIFT SERVICES MALTA LTD | MALTA | $2.5M | 110 | $23.1K |
ASCEND LABORATORIES,LLC ranks #2 among 1,458 Cefuroxime importers from India. Average shipment value of $50.0K compared to the market average of $18.6K. The closest competitors by value are M/S. RANBAXY FARMACEUTICA LTDA : and YUSEN LOGISTICS BENELUX BELGIUM.
Destination countries from 73 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $2.7M | 73 | 100.0% |
ASCEND LABORATORIES,LLC imports Cefuroxime to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $2.7M.
| Formulation | Value | Shipments |
|---|---|---|
| Pharmaceutical Products - CEFUROXIME AXETIL TABS USP 500MG 60'S | $350.0K | 7 |
| PHARMACEUTICAL PRODUCTS - CEFUROXIME AXETIL TABS USP 500MG 60'S | $269.8K | 7 |
| Pharmaceutical Products - CEFUROXIME AXETIL TABLETS USP 500MG 20'S | $226.6K | 7 |
| Pharmaceutical Products CEFUROXIME AXETI | $150.0K | 3 |
| PHARMACEUTICAL PRODUCTS :CEFUROXIME AXET | $146.0K | 4 |
| PHARMACEUTICAL PRODUCTS:CEFUROXIME AXETI | $113.3K | 4 |
| PHARMACEUTICAL PRODUCTS- CEFUROXIME AXET | $109.3K | 3 |
| Pharmaceutical Products - CEFUROXIME AXETIL TABLETS USP 250MG 60'S | $100.0K | 2 |
| PHARMACEUTICAL PRODUCTS: CEFUROXIME AXETIL TABLETS USP 250MG 60S NDC NO67877021560 |
What ASCEND LABORATORIES,LLC and other importers must comply with to import Cefuroxime from India
U.S. Food and Drug Administration (FDA)
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
India exported $27.1M worth of Cefuroxime through 6,961 shipments from 440 suppliers to 150 countries, serving 1,458 buyers globally. ASCEND LABORATORIES,LLC imports $2.7M of this total, accounting for 0.1% of India's Cefuroxime exports with 73 shipments from UNITED STATES. This is verified from 73 customs shipment records covering 35 distinct formulations.
ASCEND LABORATORIES,LLC's average Cefuroxime order value is $37.5K per consignment, based on 73 shipments totaling $2.7M. ASCEND LABORATORIES,LLC is based in UNITED STATES and ranks #2 among all Cefuroxime importers from India by value. The company sources from 1 verified supplier in India.
ASCEND LABORATORIES,LLC sources Cefuroxime from 1 verified Indian supplier: ALKEM LABORATORIES LIMITED ($2.7M, 100.0%). This is based on 73 customs records.
ASCEND LABORATORIES,LLC ranks #2 among 1,458 Cefuroxime importers from India with a 0.1% market share. The top 3 importers are M/S. RANBAXY FARMACEUTICA LTDA : ($3.5M), ASCEND LABORATORIES,LLC ($3.1M), YUSEN LOGISTICS BENELUX BELGIUM ($3.1M). ASCEND LABORATORIES,LLC processed 73 shipments from UNITED STATES.
ASCEND LABORATORIES,LLC also imports these advanced antibiotics products. Each links to the detailed product page.
ASCEND LABORATORIES,LLC imports 25 products worth $163.5M. Beyond Cefuroxime, top products include Metformin, Cephalexin, Amlodipine, Gabapentin, Ibuprofen. View the complete ASCEND LABORATORIES,LLC profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Cefuroxime — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for ASCEND LABORATORIES,LLC's Cefuroxime imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
ASCEND LABORATORIES,LLC
Full Company Profile →
25 products · $163.5M total trade · 12 categories
| $100.0K |
| 2 |
| Pharmaceutical Products - CEFUROXIME AXETIL TABS USP 500MG 60'S | $100.0K | 2 |
ASCEND LABORATORIES,LLC imports 35 distinct Cefuroxime formulations from India. The top formulation is Pharmaceutical Products - CEFUROXIME AXETIL TABS USP 500MG 6 with 7 shipments worth $350.0K.
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 150+ countries, 1,458+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for ASCEND LABORATORIES,LLC.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cefuroxime. For current order-level data, contact TransData Nexus.